CVRX CVRx, Inc.

$4.95 +2.48%

Healthcare · Surgical & Medical Instruments & Apparatus

CVRx, Inc. (CVRX) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $131 million. Shares last traded at $4.95, 56.2% below their 52-week high. Over the past year the stock is down 12.4%. Net profit margin is -94.1%, below the peer median of -7.6%. Revenue grew 10.4% year over year.

Market Cap

$131M

Shares Out

26.5M

EPS (TTM)

$-3.72

P/E Ratio

—

P/S Ratio

2.32

P/B Ratio

4.51

Dividend / Share

—

Dividend Yield

—

52-Week High

$11.30

52-Week Low

$4.38

Volume

9,667

Avg Vol (3m)

15,063.571

Performance

+1.12%

-17.91%

-42.58%

-40.58%

YTD

-29.99%

-12.39%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

36.35

SMA (50)

$6.39

SMA (200)

$7.73

Price vs SMA50

-22.50%

Price vs SMA200

-35.95%

ATR (14)

$0.44

Financials

Revenue

$57M

Net Income

$-53M

Gross Margin

85.3%

Operating Margin

-90.5%

Net Margin

-94.1%

Return on Equity

-183.1%

Return on Assets

-53.5%

Current Ratio

10.20

Debt / Equity

2.01

Revenue Growth (YoY)

+10.4%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.50	2026-05-12
FY 2025	$-2.04	2026-02-13
Q3 2025	$-1.59	2025-11-06
Q2 2025	$-1.10	2025-08-05
Q1 2026	$-0.53	2026-05-12
FY 2025	$-2.65	2026-02-13

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

CVRX vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

2.32 / 2.52 med

-8% discount

Net margin vs peers

-94.1% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.